Monoclonal Antibody Manufacturing Grants in New York (USA)
GrantID: 70275
Grant Funding Amount Low: $750,000
Deadline: May 31, 2025
Grant Amount High: $750,000
Summary
Advance innovative and bold ideas that enhance production efficiency and improve overall process economics for mAb production, resulting in a low cost-of-goods. This includes, but is not limited to alternative hosts to mammalian cell culture, alternative to standard downstream purification methods, reduction in material costs, push the boundaries of current technology by harnessing disruptive innovations, possibly from parallel industries, and identify process improvements to reduce manufacturing costs.
Eligible Regions
Interests
Eligible Requirements
Grant Detailed Description
View Full Grant Details
Additional Criteria of Eligibility
Additional Funding in Information
Estimated Size of Grant
Contact Info
Funding Source
Overview
This grant is meant to financially support organizations or entities that focus their efforts on, but not limited to: Business & Commerce, Health & Medical, Higher Education, International, Municipalities, Non-Profit Support Services, Research & Evaluation, Science, Technology Research & Development, Technology, Women in New York (USA).